Access to mental healthcare: how should pharma companies channel their efforts?
Monday, 10 October 2016
Published on Huffington Post
The authors share their thoughts and findings on access to mental healthcare with the aim of starting a conversation about how manufacturers’ efforts can be channeled in the best directions, and to identify where more can be done.
In their article, Suvi Karuranga, Researcher and Jayasree K. Iyer, Executive Director at the Access to Medicine Foundation, describe the challenges, the medicines and the ways that the pharmaceutical industry is currently engaged with issues surrounding mental health, in the hopes that a clear direction on what actions are needed can be discussed.